摘要
目的 探讨阴道炎治疗中保妇康栓辅助治疗的效果以及对炎症因子的影响。方法 选取2023年2月至2024年12月诊治的阴道炎患者68例,随机分为观察组(保妇康栓辅助雌激素软膏治疗)和对照组(雌激素软膏)各34例,对比效果。结果 治疗后,观察组疼痛、白带异常、异味、瘙痒各项症状评分均低于对照组(P<0.05);观察组C反应蛋白、降钙素原、白细胞介素-6、高度异质性蛋白等炎症因子水平均低于对照组(P<0.05);观察组不良反应发生率5.88%,低于对照组的11.76%(P>0.05)。结论 保妇康栓辅助雌激素软膏治疗阴道炎,可显著改善患者临床症状,有效下调炎症因子水平,且不会增加不良反应风险,临床应用安全性与有效性均佳。
关键词: 阴道炎;保妇康栓;雌激素软膏;炎症因子
Abstract
Objective To investigate the efficacy of Baofukang Suppository as an adjuvant therapy in the treatment of vaginitis and its impact on inflammatory factors. Methods A total of 68 patients with vaginitis diagnosed and treated from February 2023 to December 2024 were selected and randomly divided into an observation group (Baofukang Suppository combined with estrogen ointment) and a control group (estrogen ointment), with 34 cases in each group, respectively. The therapeutic effects were compared. Results After treatment, the scores for pain, abnormal vaginal discharge, odor, and pruritus in the observation group were significantly lower than those in the control group (P<0.05). The levels of inflammatory factors such as C-reactive protein (CRP), procalcitonin, interleukin-6 (IL-6), and high heterogeneity protein in the observation group were also significantly lower than those in the control group (P<0.05). The incidence of adverse reactions in the observation group was 5.88%, lower than that in the control group (11.76%) (P>0.05). Conclusion The combination of Baofukang Suppository and estrogen ointment in the treatment of vaginitis can significantly improve clinical symptoms, effectively reduce inflammatory factor levels, and does not increase the risk of adverse reactions. Both the safety and efficacy of this clinical application are excellent.
Key words: Vaginitis; Baofukang suppository; Estrogen ointment; Inflammatory factors
参考文献 References
[1] 胡露,舒文学,朱安林.探究保妇康栓与雌激素软膏联合治疗糖尿病性阴道炎的临床疗效及对阴道菌群平衡的调节作用[J].糖尿病新世界,2024,27(22):180-182, 186.
[2] 胡绿梅,李静,李燕飞.保妇康栓联合伊曲康唑治疗霉菌性阴道炎的效果及对患者临床症状改善和复发率的影响[J].当代医学,2024,30(11):84-87.
[3] 潘月琴,周丹.甲硝唑片和保妇康凝胶联合普罗雌烯乳膏治疗老年性阴道炎的效果及对炎性因子水平的影响[J].系统医学,2024,9(6):154-156164.
[4] 古力其曼•艾孜木江,赵骏达,马俊旗.抗HPV生物蛋白敷料联合保妇康栓对慢性宫颈炎合并HR-HPV感染患者的疗效及对阴道微生态的影响[J].中国微生态学杂志, 2024,36(1):90-94.
[5] 李露.重组人干扰素α2b阴道泡腾胶囊联合保妇康栓治疗CIN合并高危型HPV感染的临床效果[J].临床合理用药杂志,2024,17(31):116-119.
[6] 沈招娣.桂枝茯苓胶囊联合保妇康栓治疗细菌性阴道炎并盆腔炎的疗效及对炎性反应和睡眠质量的影响[J].临床合理用药杂志,2023,16(30):121-124.
[7] 徐文俊,许蔚倩,李燕妮,何佶励.益气健脾清带汤联合保妇康栓对老年阴道炎患者的作用观察[J].中国中医药科技,2023,30(5):983-985.
[8] 黄永群,程虹,沈方方,王亚男.保妇康凝胶辅助治疗对老年阴道炎患者炎症反应及MDA、ET-1水平的影响[J].中国老年学杂志,2023,43(3):594-597.
[9] 余美芳,刘霞.普罗雌烯阴道胶丸联合保妇康栓对绝经后萎缩性阴道炎患者的临床治疗分析[J].黑龙江中医药, 2023,52(3):18-20.